Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Sinopharm Group Co., Ltd.
  6. News
  7. Summary
    1099   CNE100000FN7

SINOPHARM GROUP CO., LTD.

(1099)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sinopharm Seeks Emergency-Use Approval in Brazil for COVID-19 Vaccine

07/26/2021 | 08:31pm EDT


ę MT Newswires 2021
All news about SINOPHARM GROUP CO., LTD.
09/24CANSINO BIOLOGICS : CanSinoBIO's COVID vaccine, tested at lower dosage, safe for children ..
RE
09/21CLEARBRIDGE HEALTH : Receives Second Second Batch of Sinopharm COVID-19 Vaccines
MT
09/17Sinopharm's COVID booster reverses antibody decline, enhances cell-based responses - st..
RE
09/14BIOALPHA BERHAD : Unit Calls Off COVID-19 Vaccine Import Deal with Zuellig Pharma
MT
09/13EVEREST MEDICINES : to bring Canadian biotech's potential COVID shots to China, other mark..
RE
09/11SINOPHARM : 2021 Interim Report
PU
09/09DUOPHARMA BIOTECH BERHAD : Refutes Reports of Authorizing Bintai Healthcare as Sinopharm's..
MT
09/08BINTAI KINDEN BERHAD : Unit Signs Partnership for Distribution of Sinopharm's COVID-19 Vac..
MT
09/07Singapore Shares Close Higher; Healthway Medical Climbs 6% on Sinopharm Vaccine Deal
MT
09/07HEALTHWAY MEDICAL : to Start Offering Sinopharm COVID-19 Vaccine, Shares Up 6%
MT
More news
Financials
Sales 2021 525 B 81 188 M 81 188 M
Net income 2021 8 194 M 1 268 M 1 268 M
Net Debt 2021 23 842 M 3 690 M 3 690 M
P/E ratio 2021 6,42x
Yield 2021 4,36%
Capitalization 52 484 M 8 117 M 8 123 M
EV / Sales 2021 0,15x
EV / Sales 2022 0,12x
Nbr of Employees 108 370
Free-Float 43,0%
Chart SINOPHARM GROUP CO., LTD.
Duration : Period :
Sinopharm Group Co., Ltd. Technical Analysis Chart | 1099 | CNE100000FN7 | MarketScreener
Technical analysis trends SINOPHARM GROUP CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 19
Last Close Price 16,82 CNY
Average target price 23,02 CNY
Spread / Average Target 36,9%
EPS Revisions
Managers and Directors
Yong Liu President & Executive Director
Xiao Juan Li Chief Financial Officer
Fang Yao Chairman-Supervisory Board
Qing Ming Yu Chairman
Wu Ping Tao Member-Supervisory Board
Sector and Competitors